
News|Articles|December 10, 2015
What Pharmacists Should Know about the Duration of DAPT
Christopher Betz, PharmD, BCPS, FKSHP, FASHP, professor in the department of clinical and administrative sciences at Sullivan University College of Pharmacy, discusses what pharmacists should know about the duration of dual antiplatelet therapy.
Advertisement
Christopher Betz, PharmD, BCPS, FKSHP, FASHP, professor in the department of clinical and administrative sciences at Sullivan University College of Pharmacy, discusses what pharmacists should know about the duration of dual antiplatelet therapy.
This video was recorded at the 2015 American Society of Health-System Pharmacists Midyear Meeting.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Nipah Outbreak in India Poses Low Global Risk Despite Lack of Approved Treatments
2
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
3
Q&A: Making Plant-Based Eating Practical in Pharmacy-Led Cardiometabolic Care
4
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
5


























